name,category,termsADP-ribosylation factor 4,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor 4,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor 4,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000356$complete proteome, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000637$GTP binding, 790000639$gtp-binding, 790000881$lipoprotein, 790000983$monomer, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
ADP-ribosylation factor 4,UP_SEQ_FEATURE[850004009$chain:ADP-ribosylation factor 4, 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant, 850118575$strand, 850118624$turn]
ATPase, Ca++ transporting, type 2C, member 1,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005835$IPR006413:ATPase, P-type, calcium-transporting, PMR1-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, type 2C, member 1,OMIM_DISEASE[520000549$benign chronic pemphigus (Hailey-Hailey disease), 520002207$Hailey-Hailey disease]
ATPase, Ca++ transporting, type 2C, member 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, type 2C, member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000624$golgi apparatus, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, type 2C, member 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850009067$chain:Calcium-transporting ATPase type 2C member 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ATX1 antioxidant protein 1 homolog (yeast),INTERPRO[450005553$IPR006121:Heavy metal transport/detoxification protein, 450016277$IPR017969:Heavy-metal-associated, conserved site]
ATX1 antioxidant protein 1 homolog (yeast),SP_PIR_KEYWORDS[790000002$3d-structure, 790000288$Chaperone, 790000356$complete proteome, 790000371$copper, 790000373$copper transport, 790000798$ion transport, 790000937$metal-binding, 790001558$transport]
ATX1 antioxidant protein 1 homolog (yeast),UP_SEQ_FEATURE[850012566$chain:Copper transport protein ATOX1, 850104136$domain:HMA, 850105852$helix, 850105958$metal ion-binding site:Copper, 850118575$strand, 850118624$turn]
BCL2-associated athanogene,INTERPRO[450000534$IPR000626:Ubiquitin, 450002727$IPR003103:Apoptosis regulator Bcl-2 protein, BAG, 450015414$IPR017093:Molecular chaperone regulator BAG-1, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup]
BCL2-associated athanogene,PIR_SUPERFAMILY[630028529$PIRSF037029:BAG_1, 630028530$PIRSF037029:molecular chaperone regulator BAG-1]
BCL2-associated athanogene,SMART[760000186$SM00213:UBQ, 760000236$SM00264:BAG]
BCL2-associated athanogene,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000053$alternative splicing, 790000109$Apoptosis, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001304$repeat, 790001592$ubl conjugation]
BCL2-associated athanogene,UP_SEQ_FEATURE[850007264$chain:BAG family molecular chaperone regulator 1, 850102404$compositionally biased region:Arg-rich, 850103084$domain:BAG, 850105602$domain:Ubiquitin-like, 850105852$helix, 850110668$region of interest:7 X 6 AA tandem repeat of E-E-X(4), 850112427$region of interest:Interaction with HSPA8, 850112702$region of interest:Interaction with PPP1R15A, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
Hermansky-Pudlak syndrome 3,INTERPRO[450015537$IPR017216:BLOC-2 complex, Hps3 subunit]
Hermansky-Pudlak syndrome 3,OMIM_DISEASE[520002304$Hermansky-Pudlak syndrome 3]
Hermansky-Pudlak syndrome 3,PIR_SUPERFAMILY[630029048$PIRSF037473:BLOC-2 complex, Hps3 subunit, 630029049$PIRSF037473:BLOC-2_complex_Hps3]
Hermansky-Pudlak syndrome 3,SP_PIR_KEYWORDS[790000035$Albinism, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000676$Hermansky-Pudlak syndrome, 790001162$phosphoprotein, 790001212$polymorphism]
Hermansky-Pudlak syndrome 3,UP_SEQ_FEATURE[850023532$chain:Hermansky-Pudlak syndrome 3 protein, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117344$short sequence motif:Clathrin-binding, 850118574$splice variant]
MAS-related GPR, member F,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
MAS-related GPR, member F,PIR_SUPERFAMILY[630001858$PIRSF001712:mas-related G protein-coupled receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
MAS-related GPR, member F,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
MAS-related GPR, member F,UP_SEQ_FEATURE[850030541$chain:Mas-related G-protein coupled receptor member F, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
NDRG family member 4,INTERPRO[450003654$IPR004142:Ndr]
NDRG family member 4,PIR_SUPERFAMILY[630019009$PIRSF023830:Caenorhabditis elegans hypothetical protein ZK1073.1]
NDRG family member 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001162$phosphoprotein]
NDRG family member 4,UP_SEQ_FEATURE[850047002$chain:Protein NDRG4, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850118574$splice variant]
NEDD4 binding protein 2,INTERPRO[450002329$IPR002625:Smr protein/MutS2 C-terminal, 450003417$IPR003892:Ubiquitin system component Cue, 450012495$IPR013899:Region of unknown function DUF1771]
NEDD4 binding protein 2,SMART[760000408$SM00463:SMR, 760000486$SM00546:CUE]
NEDD4 binding protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
NEDD4 binding protein 2,UP_SEQ_FEATURE[850033797$chain:NEDD4-binding protein 2, 850102586$compositionally biased region:Pro-rich, 850103460$domain:CUE, 850105374$domain:Smr, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
ankyrin repeat domain 13A,INTERPRO[450001870$IPR002110:Ankyrin, 450003428$IPR003903:Ubiquitin interacting motif]
ankyrin repeat domain 13A,SMART[760000220$SM00248:ANK, 760000632$SM00726:UIM]
ankyrin repeat domain 13A,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat domain 13A,UP_SEQ_FEATURE[850005363$chain:Ankyrin repeat domain-containing protein 13A, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850117162$repeat:UIM 1, 850117163$repeat:UIM 2, 850117164$repeat:UIM 3, 850117294$sequence conflict, 850117295$sequence variant]
aspartate beta-hydroxylase domain containing 1,INTERPRO[450007154$IPR007803:Aspartyl/Asparaginyl beta-hydroxylase]
aspartate beta-hydroxylase domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000437$dioxygenase, 790000919$membrane, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001409$Signal-anchor, 790001555$transmembrane]
aspartate beta-hydroxylase domain containing 1,UP_SEQ_FEATURE[850006285$chain:Aspartate beta-hydroxylase domain- containing protein 1, 850102517$compositionally biased region:Gly-rich, 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
calreticulin,BIOCARTA[30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart)]
calreticulin,INTERPRO[450000773$IPR000886:Endoplasmic reticulum, targeting sequence, 450001404$IPR001580:Calreticulin/calnexin, 450008191$IPR009033:Calreticulin/calnexin, P, 450008288$IPR009169:Calreticulin, 450011956$IPR013320:Concanavalin A-like lectin/glucanase, subgroup, 450016423$IPR018124:Calreticulin/calnexin, conserved site]
calreticulin,KEGG_PATHWAY[470038860$hsa04612:Antigen processing and presentation]
calreticulin,PIR_SUPERFAMILY[630002474$PIRSF002356:Calreticulin]
calreticulin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000211$calcium, 790000212$calcium binding, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000530$extracellular matrix, 790000616$glycoprotein, 790000784$integrin binding, 790000848$Lectin, 790000937$metal-binding, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001648$zinc]
calreticulin,UP_SEQ_FEATURE[850009200$chain:Calreticulin, 850102471$compositionally biased region:Asp/Glu/Lys-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850110284$region of interest:3 X approximate repeats, 850110424$region of interest:4 X approximate repeats, 850111124$region of interest:C-domain, 850113514$region of interest:N-domain, 850113854$region of interest:P-domain, 850115075$repeat:1-1, 850115091$repeat:1-2, 850115103$repeat:1-3, 850115113$repeat:1-4, 850115274$repeat:2-1, 850115291$repeat:2-2, 850115306$repeat:2-3, 850117294$sequence conflict, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide]
chromosome 21 open reading frame 66,INTERPRO[450011568$IPR012890:GC-rich sequence DNA-binding factor-like]
chromosome 21 open reading frame 66,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
chromosome 21 open reading frame 66,UP_SEQ_FEATURE[850020723$chain:GC-rich sequence DNA-binding factor homolog, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
chromosome 4 open reading frame 26,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
chromosome 4 open reading frame 26,UP_SEQ_FEATURE[850074179$chain:Uncharacterized protein C4orf26, 850117295$sequence variant, 850117814$signal peptide]
chromosome 4 open reading frame 36,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 4 open reading frame 36,UP_SEQ_FEATURE[850074188$chain:Uncharacterized protein C4orf36, 850117295$sequence variant]
chromosome 7 open reading frame 31,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 7 open reading frame 31,UP_SEQ_FEATURE[850074415$chain:Uncharacterized protein C7orf31, 850117295$sequence variant]
collagen, type IV, alpha 3 (Goodpasture antigen),INTERPRO[450001284$IPR001442:Type 4 procollagen, C-terminal repeat, 450007490$IPR008160:Collagen triple helix repeat]
collagen, type IV, alpha 3 (Goodpasture antigen),OMIM_DISEASE[520000235$Alport syndrome, autosomal recessive, 520002245$Hematuria, benign familial]
collagen, type IV, alpha 3 (Goodpasture antigen),PIR_SUPERFAMILY[630002387$PIRSF002258:collagen alpha 1(IV) chain]
collagen, type IV, alpha 3 (Goodpasture antigen),SMART[760000098$SM00111:C4]
collagen, type IV, alpha 3 (Goodpasture antigen),SP_PIR_KEYWORDS[790000049$Alport syndrome, 790000053$alternative splicing, 790000171$basement membrane, 790000256$cell adhesion, 790000257$cell binding, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790000811$isopeptide bond, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001565$trimer, 790001568$triple helix, 790001592$ubl conjugation]
collagen, type IV, alpha 3 (Goodpasture antigen),UP_SEQ_FEATURE[850012210$chain:Collagen alpha-3(IV) chain, 850067264$chain:Tumstatin, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102766$cross-link:S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-1533), 850102773$cross-link:S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-1651), 850102883$disulfide bond, 850103388$domain:Collagen IV NC1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850110686$region of interest:7S domain, 850111602$region of interest:Epitope recognized by Goodpasture antibodies, 850114488$region of interest:Required for the anti-angiogenic activity of tumstatin, 850114489$region of interest:Required for the anti-tumor cell activity of tumstatin, 850114937$region of interest:Triple-helical region, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide, 850118038$site:Cleavage; by collagenase, 850118574$splice variant]
complexin 1,INTERPRO[450008093$IPR008849:Synaphin]
complexin 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000522$exocytosis, 790001027$neurotransmitter transport, 790001558$transport]
complexin 1,UP_SEQ_FEATURE[850012405$chain:Complexin-1, 850112942$region of interest:Interaction with the SNARE complex]
decorin,COG_ONTOLOGY[90000070$Function unknown]
decorin,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450014674$IPR016352:Small leucine-rich proteoglycan, class I, decorin/asporin/byglycan]
decorin,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
decorin,OMIM_DISEASE[520001209$Corneal dystrophy, congenital stromal]
decorin,PIR_SUPERFAMILY[630002608$PIRSF002490:class I small leucine-rich proteoglycan, decorin/asporin/byglycan types, 630002609$PIRSF002490:SLRP_I]
decorin,SMART[760000007$SM00013:LRRNT, 760000333$SM00369:LRR_TYP]
decorin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000308$chondroitin sulfate proteoglycan, 790000346$collagen binding, 790000356$complete proteome, 790000424$dermatan sulfate, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000530$extracellular matrix, 790000550$fibroblast, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001484$tandem repeat]
decorin,UP_SEQ_FEATURE[850014440$chain:Decorin, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
gasdermin C,INTERPRO[450007034$IPR007677:DFNA5 protein]
gasdermin C,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism]
gasdermin C,UP_SEQ_FEATURE[850020653$chain:Gasdermin-C, 850117295$sequence variant]
growth arrest-specific 8,SP_PIR_KEYWORDS[790000267$cell projection, 790000321$cilium, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000557$flagellum, 790000624$golgi apparatus, 790000960$microtubule, 790001212$polymorphism]
growth arrest-specific 8,UP_SEQ_FEATURE[850022456$chain:Growth arrest-specific protein 8, 850113445$region of interest:Microtubule-binding, 850114197$region of interest:Regulates microtubule-binding, 850117295$sequence variant]
heterogeneous nuclear ribonucleoprotein U-like 1,INTERPRO[450001654$IPR001870:B302 (SPRY)-like, 450002665$IPR003034:DNA-binding SAP, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450016640$IPR018355:SPla/RYanodine receptor subgroup]
heterogeneous nuclear ribonucleoprotein U-like 1,SMART[760000394$SM00449:SPRY, 760000456$SM00513:SAP]
heterogeneous nuclear ribonucleoprotein U-like 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000953$methylation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation, 790001613$viral nucleoprotein]
heterogeneous nuclear ribonucleoprotein U-like 1,UP_SEQ_FEATURE[850023598$chain:Heterogeneous nuclear ribonucleoprotein U-like protein 1, 850102448$compositionally biased region:Asn-rich, 850102485$compositionally biased region:Gln-rich, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850102608$compositionally biased region:Tyr-rich, 850103078$domain:B30.2/SPRY, 850105257$domain:SAP, 850106258$modified residue, 850110480$region of interest:5 X 3 AA repeats of R-G-G, 850113596$region of interest:Necessary for interaction with BRD7 and transcriptional activation, 850113613$region of interest:Necessary for interaction with HRMT1L1, 850113654$region of interest:Necessary for interaction with TP53, 850113713$region of interest:Necessary for transcription repression, 850115075$repeat:1-1, 850115091$repeat:1-2, 850115103$repeat:1-3, 850115113$repeat:1-4, 850115116$repeat:1-5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
hydroxysteroid (11-beta) dehydrogenase 1,BIOCARTA[30000311$h_vobesityPathway:Visceral Fat Deposits and the Metabolic Syndrome]
hydroxysteroid (11-beta) dehydrogenase 1,COG_ONTOLOGY[90000032$Cell envelope biogenesis, outer membrane]
hydroxysteroid (11-beta) dehydrogenase 1,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
hydroxysteroid (11-beta) dehydrogenase 1,KEGG_PATHWAY[470038739$hsa00140:Steroid hormone biosynthesis, 470038740$hsa00150:Androgen and estrogen metabolism, 470038890$hsa04960:Aldosterone-regulated sodium reabsorption]
hydroxysteroid (11-beta) dehydrogenase 1,OMIM_DISEASE[520001245$Cortisone reductase deficiency]
hydroxysteroid (11-beta) dehydrogenase 1,PIR_SUPERFAMILY[630000148$PIRSF000126:11beta-hydroxysteroid dehydrogenase]
hydroxysteroid (11-beta) dehydrogenase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000873$lipid metabolism, 790000919$membrane, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001409$Signal-anchor, 790001442$steroid metabolism, 790001555$transmembrane, 790001556$transmembrane protein]
hydroxysteroid (11-beta) dehydrogenase 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000555$binding site:Substrate, 850012641$chain:Corticosteroid 11-beta-dehydrogenase isozyme 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850106307$nucleotide phosphate-binding region:NADP, 850117295$sequence variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
interferon induced transmembrane protein 5,INTERPRO[450006944$IPR007593:Interferon-induced transmembrane protein]
interferon induced transmembrane protein 5,PIR_SUPERFAMILY[630013367$PIRSF016581:interferon-induced transmembrane protein]
interferon induced transmembrane protein 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
interferon induced transmembrane protein 5,UP_SEQ_FEATURE[850026467$chain:Interferon-induced transmembrane protein 5, 850117295$sequence variant, 850118623$transmembrane region]
interleukin 1 family, member 8 (eta),INTERPRO[450000847$IPR000975:Interleukin-1]
interleukin 1 family, member 8 (eta),SMART[760000107$SM00125:IL1]
interleukin 1 family, member 8 (eta),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000402$cytokine, 790001212$polymorphism, 790001363$Secreted]
interleukin 1 family, member 8 (eta),UP_SEQ_FEATURE[850026495$chain:Interleukin-1 family member 8, 850117295$sequence variant, 850118574$splice variant]
kelch-like 9 (Drosophila),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
kelch-like 9 (Drosophila),KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
kelch-like 9 (Drosophila),PIR_SUPERFAMILY[630028538$PIRSF037037:kelch-like protein, gigaxonin type, 630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
kelch-like 9 (Drosophila),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch-like 9 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000819$kelch repeat, 790001162$phosphoprotein, 790001304$repeat, 790001593$ubl conjugation pathway]
kelch-like 9 (Drosophila),UP_SEQ_FEATURE[850027157$chain:Kelch-like protein 9, 850103083$domain:BACK, 850103177$domain:BTB, 850106258$modified residue, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6]
lamin B2,BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
lamin B2,INTERPRO[450001165$IPR001322:Intermediate filament, C-terminal, 450001474$IPR001664:Intermediate filament protein, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
lamin B2,OMIM_DISEASE[520002910$Lipodystrophy, partial, acquired]
lamin B2,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
lamin B2,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000788$Intermediate filament, 790000881$lipoprotein, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001236$prenylation]
lamin B2,UP_SEQ_FEATURE[850027918$chain:Lamin-B2, 850102469$compositionally biased region:Asp/Glu-rich (highly acidic; could be involved in chromatin binding), 850105890$lipid moiety-binding region:S-farnesyl cysteine, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113286$region of interest:Linker 2, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal]
mannosidase, alpha, class 2B, member 1,INTERPRO[450000514$IPR000602:Glycoside hydrolase, family 38, core, 450010510$IPR011682:Glycosyl hydrolases 38, C-terminal, 450012394$IPR013780:Glycosyl hydrolase, family 13, all-beta, 450013783$IPR015341:Glycoside hydrolase, family 38, central region]
mannosidase, alpha, class 2B, member 1,KEGG_PATHWAY[470038767$hsa00511:Other glycan degradation, 470038840$hsa04142:Lysosome]
mannosidase, alpha, class 2B, member 1,OMIM_DISEASE[520003070$Mannosidosis, alpha-, types I and II]
mannosidase, alpha, class 2B, member 1,PIR_SUPERFAMILY[630012526$PIRSF015759:lysosomal alpha-mannosidase]
mannosidase, alpha, class 2B, member 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000617$glycosidase, 790000743$hydrolase, 790000897$lysosome, 790000937$metal-binding, 790001212$polymorphism, 790001405$signal, 790001648$zinc, 790001652$zymogen]
mannosidase, alpha, class 2B, member 1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850029368$chain:Lysosomal alpha-mannosidase, 850029369$chain:Lysosomal alpha-mannosidase A peptide, 850029370$chain:Lysosomal alpha-mannosidase B peptide, 850029371$chain:Lysosomal alpha-mannosidase C peptide, 850029372$chain:Lysosomal alpha-mannosidase D peptide, 850029373$chain:Lysosomal alpha-mannosidase E peptide, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106218$metal ion-binding site:Zinc, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),INTERPRO[450000890$IPR001017:Dehydrogenase, E1 component, 450004931$IPR005475:Transketolase, central region, 450010434$IPR011603:2-oxoglutarate dehydrogenase, E1 component]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),KEGG_PATHWAY[470038726$hsa00020:Citrate cycle (TCA cycle), 470038751$hsa00310:Lysine degradation, 470038756$hsa00380:Tryptophan metabolism]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),OMIM_DISEASE[520000227$Alpha-ketoglutarate dehydrogenase deficiency]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),PIR_SUPERFAMILY[630000186$PIRSF000157:2-oxoglutarate dehydrogenase, E1 component, 630000187$PIRSF000157:Oxoglu_dh_E1]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000615$glycolysis, 790000811$isopeptide bond, 790000969$mitochondrion, 790001092$oxidoreductase, 790001212$polymorphism, 790001500$thiamin pyrophosphate, 790001503$thiamine pyrophosphate, 790001550$transit peptide, 790001564$tricarboxylic acid cycle, 790001592$ubl conjugation]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),UP_SEQ_FEATURE[850001162$chain:2-oxoglutarate dehydrogenase, mitochondrial, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
potassium inwardly-rectifying channel, subfamily J, member 14,INTERPRO[450001625$IPR001838:Potassium channel, inwardly rectifying, Kir-like, 450012143$IPR013518:Potassium channel, inwardly rectifying, Kir, cytoplasmic, 450012146$IPR013521:Potassium channel, inwardly rectifying, Kir, conserved region 2, 450014771$IPR016449:Potassium channel, inwardly rectifying, Kir]
potassium inwardly-rectifying channel, subfamily J, member 14,PIR_SUPERFAMILY[630005389$PIRSF005465:G protein-activated inward rectifier potassium channel, 630005390$PIRSF005465:GIRK_kir]
potassium inwardly-rectifying channel, subfamily J, member 14,SP_PIR_KEYWORDS[790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001212$polymorphism, 790001226$potassium, 790001229$potassium transport, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
potassium inwardly-rectifying channel, subfamily J, member 14,UP_SEQ_FEATURE[850006758$chain:ATP-sensitive inward rectifier potassium channel 14, 850111830$region of interest:H5 (pore-forming helix), 850117295$sequence variant, 850117700$short sequence motif:Selectivity filter, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
purine-rich element binding protein B,INTERPRO[450006047$IPR006628:PUR-alpha/beta/gamma, DNA/RNA-binding]
purine-rich element binding protein B,SMART[760000619$SM00712:PUR]
purine-rich element binding protein B,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
purine-rich element binding protein B,UP_SEQ_FEATURE[850065529$chain:Transcriptional activator protein Pur- beta, 850102517$compositionally biased region:Gly-rich, 850106258$modified residue]
quaking homolog, KH domain RNA binding (mouse),INTERPRO[450003602$IPR004087:K Homology]
quaking homolog, KH domain RNA binding (mouse),OMIM_DISEASE[520002006$Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in Rheumatoid Arthritis]
quaking homolog, KH domain RNA binding (mouse),SMART[760000291$SM00322:KH]
quaking homolog, KH domain RNA binding (mouse),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000953$methylation, 790000988$mrna processing, 790000989$mrna splicing, 790000990$mRNA transport, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding, 790001399$sh3-binding, 790001551$translation regulation, 790001558$transport]
quaking homolog, KH domain RNA binding (mouse),UP_SEQ_FEATURE[850047433$chain:Protein quaking, 850104520$domain:KH, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850117711$short sequence motif:SH3-binding, 850118574$splice variant]
signal-regulatory protein gamma,INTERPRO[450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003158$IPR003597:Immunoglobulin C1-set, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
signal-regulatory protein gamma,PIR_SUPERFAMILY[630029643$PIRSF038063:Signal-regulatory protein beta-1]
signal-regulatory protein gamma,SMART[760000355$SM00407:IGc1, 760000357$SM00409:IG]
signal-regulatory protein gamma,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
signal-regulatory protein gamma,UP_SEQ_FEATURE[850060833$chain:Signal-regulatory protein gamma, 850102883$disulfide bond, 850104353$domain:Ig-like C1-type 1, 850104354$domain:Ig-like C1-type 2, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 6 (neurotransmitter transporter, creatine), member 8,BBID[10000019$12.IL-6_type_cytok-signal-transduct]
solute carrier family 6 (neurotransmitter transporter, creatine), member 8,COG_ONTOLOGY[90000073$General function prediction only]
solute carrier family 6 (neurotransmitter transporter, creatine), member 8,INTERPRO[450000148$IPR000175:Sodium:neurotransmitter symporter, 450002629$IPR002984:Sodium:neurotransmitter symporter, creatine]
solute carrier family 6 (neurotransmitter transporter, creatine), member 8,OMIM_DISEASE[520001268$Creatine deficiency syndrome, X-linked]
solute carrier family 6 (neurotransmitter transporter, creatine), member 8,PIR_SUPERFAMILY[630002561$PIRSF002444:gamma-aminobutyric acid transporter]
solute carrier family 6 (neurotransmitter transporter, creatine), member 8,SP_PIR_KEYWORDS[790000199$brain, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000798$ion transport, 790000852$leucine zipper, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001418$Sodium, 790001421$Sodium transport, 790001430$spinal cord, 790001473$Symport, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
solute carrier family 6 (neurotransmitter transporter, creatine), member 8,UP_SEQ_FEATURE[850061196$chain:Sodium- and chloride-dependent creatine transporter 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
sushi, nidogen and EGF-like domains 1,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000373$IPR000436:Sushi/SCR/CCP, 450000637$IPR000742:EGF-like, type 3, 450001280$IPR001438:EGF-like, type 2, 450001663$IPR001881:EGF-like calcium-binding, 450003191$IPR003645:Follistatin-like, N-terminal, 450003411$IPR003886:Nidogen, extracellular region, 450003484$IPR003961:Fibronectin, type III, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450008173$IPR008957:Fibronectin, type III-like fold, 450011699$IPR013032:EGF-like region, conserved site, 450011755$IPR013111:EGF, extracellular, 450014444$IPR016060:Complement control module, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
sushi, nidogen and EGF-like domains 1,SMART[760000024$SM00032:CCP, 760000051$SM00060:FN3, 760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000246$SM00274:FOLN, 760000479$SM00539:NIDO]
sushi, nidogen and EGF-like domains 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001471$sushi]
sushi, nidogen and EGF-like domains 1,UP_SEQ_FEATURE[850063078$chain:Sushi, nidogen and EGF-like domain- containing protein 1, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103598$domain:EGF-like 10, 850103602$domain:EGF-like 11; calcium-binding, 850103604$domain:EGF-like 12; calcium-binding, 850103605$domain:EGF-like 13, 850103607$domain:EGF-like 14, 850103609$domain:EGF-like 15, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103687$domain:EGF-like 4; calcium-binding, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850103698$domain:EGF-like 7, 850103700$domain:EGF-like 8, 850103702$domain:EGF-like 9, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850103860$domain:Fibronectin type-III 3, 850104010$domain:Follistatin-like 1, 850104011$domain:Follistatin-like 2, 850104854$domain:NIDO, 850105415$domain:Sushi, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
thymic stromal lymphopoietin,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
thymic stromal lymphopoietin,SP_PIR_KEYWORDS[790000356$complete proteome, 790000402$cytokine, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
thymic stromal lymphopoietin,UP_SEQ_FEATURE[850064430$chain:Thymic stromal lymphopoietin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide]
titin,INTERPRO[450000143$IPR000169:Peptidase, cysteine peptidase active site, 450000351$IPR000408:Regulator of chromosome condensation, RCC1, 450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450003484$IPR003961:Fibronectin, type III, 450003485$IPR003962:Fibronectin, type III subdomain, 450003678$IPR004168:PPAK motif, 450006486$IPR007110:Immunoglobulin-like, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450008173$IPR008957:Fibronectin, type III-like fold, 450011742$IPR013098:Immunoglobulin I-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold, 450013576$IPR015129:Titin Z, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450018010$IPR019775:WD40 repeat, conserved site]
titin,KEGG_PATHWAY[470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038922$hsa05414:Dilated cardiomyopathy]
titin,OMIM_DISEASE[520000769$Cardiomyopathy, dilated, 1G, 520000805$Cardiomyopathy, familial hypertrophic, 9, 520003438$Muscular dystrophy, limb-girdle, type 2J, 520003500$Myopathy, early-onset, with fatal cardiomyopathy, 520003508$Myopathy, proximal, with early respiratory muscle involvement, 520004877$Tibial muscular dystrophy, tardive]
titin,SMART[760000051$SM00060:FN3, 760000193$SM00220:S_TKc, 760000356$SM00408:IGc2, 760000357$SM00409:IG]
titin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000218$calmodulin-binding, 790000245$Cardiomyopathy, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000768$Immunoglobulin domain, 790000811$isopeptide bond, 790000819$kelch repeat, 790000825$kinase, 790000865$limb-girdle muscular dystrophy, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001388$serine/threonine-protein kinase, 790001537$tpr repeat, 790001547$transferase, 790001592$ubl conjugation, 790001638$wd repeat]
titin,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850064515$chain:Titin, 850102378$compositionally biased region:Ala-rich, 850102507$compositionally biased region:Glu-rich, 850102566$compositionally biased region:Poly-Arg, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102582$compositionally biased region:Poly-Thr, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102883$disulfide bond, 850103800$domain:Fibronectin type-III 1, 850103801$domain:Fibronectin type-III 10, 850103802$domain:Fibronectin type-III 100, 850103803$domain:Fibronectin type-III 101, 850103804$domain:Fibronectin type-III 102, 850103805$domain:Fibronectin type-III 103, 850103806$domain:Fibronectin type-III 104, 850103807$domain:Fibronectin type-III 105, 850103808$domain:Fibronectin type-III 106, 850103809$domain:Fibronectin type-III 107, 850103810$domain:Fibronectin type-III 108, 850103811$domain:Fibronectin type-III 109, 850103812$domain:Fibronectin type-III 11, 850103813$domain:Fibronectin type-III 110, 850103814$domain:Fibronectin type-III 111, 850103815$domain:Fibronectin type-III 112, 850103816$domain:Fibronectin type-III 113, 850103817$domain:Fibronectin type-III 114, 850103818$domain:Fibronectin type-III 115, 850103819$domain:Fibronectin type-III 116, 850103820$domain:Fibronectin type-III 117, 850103821$domain:Fibronectin type-III 118, 850103822$domain:Fibronectin type-III 119, 850103823$domain:Fibronectin type-III 12, 850103824$domain:Fibronectin type-III 120, 850103825$domain:Fibronectin type-III 121, 850103826$domain:Fibronectin type-III 122, 850103827$domain:Fibronectin type-III 123, 850103828$domain:Fibronectin type-III 124, 850103829$domain:Fibronectin type-III 125, 850103830$domain:Fibronectin type-III 126, 850103831$domain:Fibronectin type-III 127, 850103832$domain:Fibronectin type-III 128, 850103833$domain:Fibronectin type-III 129, 850103835$domain:Fibronectin type-III 13, 850103836$domain:Fibronectin type-III 130, 850103837$domain:Fibronectin type-III 131, 850103838$domain:Fibronectin type-III 132, 850103843$domain:Fibronectin type-III 14, 850103844$domain:Fibronectin type-III 15, 850103845$domain:Fibronectin type-III 16, 850103846$domain:Fibronectin type-III 17, 850103847$domain:Fibronectin type-III 18, 850103848$domain:Fibronectin type-III 19, 850103849$domain:Fibronectin type-III 2, 850103850$domain:Fibronectin type-III 20, 850103851$domain:Fibronectin type-III 21, 850103852$domain:Fibronectin type-III 22, 850103853$domain:Fibronectin type-III 23, 850103854$domain:Fibronectin type-III 24, 850103855$domain:Fibronectin type-III 25, 850103856$domain:Fibronectin type-III 26, 850103857$domain:Fibronectin type-III 27, 850103858$domain:Fibronectin type-III 28, 850103859$domain:Fibronectin type-III 29, 850103860$domain:Fibronectin type-III 3, 850103861$domain:Fibronectin type-III 30, 850103862$domain:Fibronectin type-III 31, 850103863$domain:Fibronectin type-III 32, 850103864$domain:Fibronectin type-III 33, 850103865$domain:Fibronectin type-III 34, 850103866$domain:Fibronectin type-III 35, 850103867$domain:Fibronectin type-III 36, 850103868$domain:Fibronectin type-III 37, 850103869$domain:Fibronectin type-III 38, 850103870$domain:Fibronectin type-III 39, 850103871$domain:Fibronectin type-III 4, 850103872$domain:Fibronectin type-III 40, 850103873$domain:Fibronectin type-III 41, 850103874$domain:Fibronectin type-III 42, 850103875$domain:Fibronectin type-III 43, 850103876$domain:Fibronectin type-III 44, 850103877$domain:Fibronectin type-III 45, 850103878$domain:Fibronectin type-III 46, 850103879$domain:Fibronectin type-III 47, 850103880$domain:Fibronectin type-III 48, 850103881$domain:Fibronectin type-III 49, 850103882$domain:Fibronectin type-III 5, 850103883$domain:Fibronectin type-III 50, 850103884$domain:Fibronectin type-III 51, 850103885$domain:Fibronectin type-III 52, 850103886$domain:Fibronectin type-III 53, 850103887$domain:Fibronectin type-III 54, 850103888$domain:Fibronectin type-III 55, 850103889$domain:Fibronectin type-III 56, 850103890$domain:Fibronectin type-III 57, 850103891$domain:Fibronectin type-III 58, 850103892$domain:Fibronectin type-III 59, 850103893$domain:Fibronectin type-III 6, 850103894$domain:Fibronectin type-III 60, 850103895$domain:Fibronectin type-III 61, 850103896$domain:Fibronectin type-III 62, 850103897$domain:Fibronectin type-III 63, 850103898$domain:Fibronectin type-III 64, 850103899$domain:Fibronectin type-III 65, 850103900$domain:Fibronectin type-III 66, 850103901$domain:Fibronectin type-III 67, 850103902$domain:Fibronectin type-III 68, 850103903$domain:Fibronectin type-III 69, 850103905$domain:Fibronectin type-III 7, 850103906$domain:Fibronectin type-III 70, 850103907$domain:Fibronectin type-III 71, 850103908$domain:Fibronectin type-III 72, 850103909$domain:Fibronectin type-III 73, 850103910$domain:Fibronectin type-III 74, 850103911$domain:Fibronectin type-III 75, 850103912$domain:Fibronectin type-III 76, 850103913$domain:Fibronectin type-III 77, 850103914$domain:Fibronectin type-III 78, 850103915$domain:Fibronectin type-III 79, 850103917$domain:Fibronectin type-III 8, 850103918$domain:Fibronectin type-III 80, 850103919$domain:Fibronectin type-III 81, 850103920$domain:Fibronectin type-III 82, 850103921$domain:Fibronectin type-III 83, 850103922$domain:Fibronectin type-III 84, 850103923$domain:Fibronectin type-III 85, 850103924$domain:Fibronectin type-III 86, 850103925$domain:Fibronectin type-III 87, 850103926$domain:Fibronectin type-III 88, 850103927$domain:Fibronectin type-III 89, 850103930$domain:Fibronectin type-III 9, 850103931$domain:Fibronectin type-III 90, 850103932$domain:Fibronectin type-III 91, 850103933$domain:Fibronectin type-III 92, 850103934$domain:Fibronectin type-III 93, 850103935$domain:Fibronectin type-III 94, 850103936$domain:Fibronectin type-III 95, 850103937$domain:Fibronectin type-III 96, 850103938$domain:Fibronectin type-III 97, 850103939$domain:Fibronectin type-III 98, 850103940$domain:Fibronectin type-III 99, 850104200$domain:Ig-like 1, 850104201$domain:Ig-like 10, 850104202$domain:Ig-like 100, 850104203$domain:Ig-like 101, 850104204$domain:Ig-like 102, 850104205$domain:Ig-like 103, 850104206$domain:Ig-like 104, 850104207$domain:Ig-like 105, 850104208$domain:Ig-like 106, 850104209$domain:Ig-like 107, 850104210$domain:Ig-like 108, 850104211$domain:Ig-like 109, 850104212$domain:Ig-like 11, 850104213$domain:Ig-like 110, 850104214$domain:Ig-like 111, 850104215$domain:Ig-like 112, 850104216$domain:Ig-like 113, 850104217$domain:Ig-like 114, 850104218$domain:Ig-like 115, 850104219$domain:Ig-like 116, 850104220$domain:Ig-like 117, 850104221$domain:Ig-like 118, 850104222$domain:Ig-like 119, 850104223$domain:Ig-like 12, 850104224$domain:Ig-like 120, 850104225$domain:Ig-like 121, 850104226$domain:Ig-like 122, 850104227$domain:Ig-like 123, 850104228$domain:Ig-like 124, 850104229$domain:Ig-like 125, 850104230$domain:Ig-like 126, 850104231$domain:Ig-like 127, 850104232$domain:Ig-like 128, 850104233$domain:Ig-like 129, 850104234$domain:Ig-like 13, 850104235$domain:Ig-like 130, 850104236$domain:Ig-like 131, 850104237$domain:Ig-like 132, 850104238$domain:Ig-like 133, 850104239$domain:Ig-like 134, 850104240$domain:Ig-like 135, 850104241$domain:Ig-like 136, 850104242$domain:Ig-like 137, 850104243$domain:Ig-like 138, 850104244$domain:Ig-like 139, 850104245$domain:Ig-like 14, 850104246$domain:Ig-like 140, 850104247$domain:Ig-like 141, 850104248$domain:Ig-like 142, 850104249$domain:Ig-like 143, 850104250$domain:Ig-like 144, 850104251$domain:Ig-like 145, 850104252$domain:Ig-like 146, 850104253$domain:Ig-like 147, 850104254$domain:Ig-like 148, 850104255$domain:Ig-like 149, 850104256$domain:Ig-like 15, 850104257$domain:Ig-like 150, 850104258$domain:Ig-like 151, 850104259$domain:Ig-like 152, 850104260$domain:Ig-like 16, 850104261$domain:Ig-like 17, 850104262$domain:Ig-like 18, 850104263$domain:Ig-like 19, 850104264$domain:Ig-like 2, 850104265$domain:Ig-like 20, 850104266$domain:Ig-like 21, 850104267$domain:Ig-like 22, 850104268$domain:Ig-like 23, 850104269$domain:Ig-like 24, 850104270$domain:Ig-like 25, 850104271$domain:Ig-like 26, 850104272$domain:Ig-like 27, 850104273$domain:Ig-like 28, 850104274$domain:Ig-like 29, 850104275$domain:Ig-like 3, 850104276$domain:Ig-like 30, 850104277$domain:Ig-like 31, 850104278$domain:Ig-like 32, 850104279$domain:Ig-like 33, 850104280$domain:Ig-like 34, 850104281$domain:Ig-like 35, 850104282$domain:Ig-like 36, 850104283$domain:Ig-like 37, 850104284$domain:Ig-like 38, 850104285$domain:Ig-like 39, 850104286$domain:Ig-like 4, 850104287$domain:Ig-like 40, 850104288$domain:Ig-like 41, 850104289$domain:Ig-like 42, 850104290$domain:Ig-like 43, 850104291$domain:Ig-like 44, 850104292$domain:Ig-like 45, 850104293$domain:Ig-like 46, 850104294$domain:Ig-like 47, 850104295$domain:Ig-like 48, 850104296$domain:Ig-like 49, 850104297$domain:Ig-like 5, 850104298$domain:Ig-like 50, 850104299$domain:Ig-like 51, 850104300$domain:Ig-like 52, 850104301$domain:Ig-like 53, 850104302$domain:Ig-like 54, 850104303$domain:Ig-like 55, 850104304$domain:Ig-like 56, 850104305$domain:Ig-like 57, 850104306$domain:Ig-like 58, 850104307$domain:Ig-like 59, 850104308$domain:Ig-like 6, 850104309$domain:Ig-like 60, 850104310$domain:Ig-like 61, 850104311$domain:Ig-like 62, 850104312$domain:Ig-like 63, 850104313$domain:Ig-like 64, 850104314$domain:Ig-like 65, 850104315$domain:Ig-like 66, 850104316$domain:Ig-like 67, 850104317$domain:Ig-like 68, 850104318$domain:Ig-like 69, 850104319$domain:Ig-like 7, 850104320$domain:Ig-like 70, 850104321$domain:Ig-like 71, 850104322$domain:Ig-like 72, 850104323$domain:Ig-like 73, 850104324$domain:Ig-like 74, 850104325$domain:Ig-like 75, 850104326$domain:Ig-like 76, 850104327$domain:Ig-like 77, 850104328$domain:Ig-like 78, 850104329$domain:Ig-like 79, 850104330$domain:Ig-like 8, 850104331$domain:Ig-like 80, 850104332$domain:Ig-like 81, 850104333$domain:Ig-like 82, 850104334$domain:Ig-like 83, 850104335$domain:Ig-like 84, 850104336$domain:Ig-like 85, 850104337$domain:Ig-like 86, 850104338$domain:Ig-like 87, 850104339$domain:Ig-like 88, 850104340$domain:Ig-like 89, 850104341$domain:Ig-like 9, 850104342$domain:Ig-like 90, 850104343$domain:Ig-like 91, 850104344$domain:Ig-like 92, 850104345$domain:Ig-like 93, 850104346$domain:Ig-like 94, 850104347$domain:Ig-like 95, 850104348$domain:Ig-like 96, 850104349$domain:Ig-like 97, 850104350$domain:Ig-like 98, 850104351$domain:Ig-like 99, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850115071$region of interest:ZIS1, 850115072$region of interest:ZIS5, 850116239$repeat:Kelch 1, 850116240$repeat:Kelch 10, 850116241$repeat:Kelch 11, 850116242$repeat:Kelch 12, 850116243$repeat:Kelch 13, 850116244$repeat:Kelch 14, 850116245$repeat:Kelch 15, 850116246$repeat:Kelch 16, 850116247$repeat:Kelch 17, 850116248$repeat:Kelch 18, 850116249$repeat:Kelch 19, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850116255$repeat:Kelch 7, 850116256$repeat:Kelch 8, 850116257$repeat:Kelch 9, 850116625$repeat:PEVK 1, 850116626$repeat:PEVK 10, 850116627$repeat:PEVK 11, 850116628$repeat:PEVK 12, 850116629$repeat:PEVK 13, 850116630$repeat:PEVK 14, 850116631$repeat:PEVK 15, 850116632$repeat:PEVK 16, 850116633$repeat:PEVK 17, 850116634$repeat:PEVK 18, 850116635$repeat:PEVK 19, 850116636$repeat:PEVK 2, 850116637$repeat:PEVK 20, 850116638$repeat:PEVK 21, 850116639$repeat:PEVK 22, 850116640$repeat:PEVK 23, 850116641$repeat:PEVK 24, 850116642$repeat:PEVK 25, 850116643$repeat:PEVK 26, 850116644$repeat:PEVK 27, 850116645$repeat:PEVK 28, 850116646$repeat:PEVK 29, 850116647$repeat:PEVK 3, 850116648$repeat:PEVK 30, 850116649$repeat:PEVK 31, 850116658$repeat:PEVK 4, 850116669$repeat:PEVK 5, 850116680$repeat:PEVK 6, 850116691$repeat:PEVK 7, 850116699$repeat:PEVK 8, 850116700$repeat:PEVK 9, 850116898$repeat:RCC1 1, 850116899$repeat:RCC1 10, 850116900$repeat:RCC1 11, 850116901$repeat:RCC1 12, 850116902$repeat:RCC1 13, 850116903$repeat:RCC1 14, 850116904$repeat:RCC1 15, 850116905$repeat:RCC1 16, 850116906$repeat:RCC1 17, 850116909$repeat:RCC1 2, 850116910$repeat:RCC1 3, 850116911$repeat:RCC1 4, 850116912$repeat:RCC1 5, 850116913$repeat:RCC1 6, 850116914$repeat:RCC1 7, 850116915$repeat:RCC1 8, 850116916$repeat:RCC1 9, 850117119$repeat:TPR 1, 850117120$repeat:TPR 10, 850117121$repeat:TPR 11, 850117122$repeat:TPR 12, 850117123$repeat:TPR 13, 850117125$repeat:TPR 14, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117147$repeat:TPR 9, 850117171$repeat:WD 1, 850117172$repeat:WD 10, 850117173$repeat:WD 11, 850117174$repeat:WD 12, 850117175$repeat:WD 13, 850117176$repeat:WD 14, 850117177$repeat:WD 15, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9, 850117278$repeat:Z-repeat 1, 850117279$repeat:Z-repeat 2, 850117280$repeat:Z-repeat 3, 850117281$repeat:Z-repeat 4, 850117282$repeat:Z-repeat 5, 850117283$repeat:Z-repeat 6, 850117284$repeat:Z-repeat 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
triggering receptor expressed on myeloid cells 2,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
triggering receptor expressed on myeloid cells 2,OMIM_DISEASE[520003553$Nasu-Hakola disease]
triggering receptor expressed on myeloid cells 2,SMART[760000357$SM00409:IG]
triggering receptor expressed on myeloid cells 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
triggering receptor expressed on myeloid cells 2,UP_SEQ_FEATURE[850066587$chain:Triggering receptor expressed on myeloid cells 2, 850102883$disulfide bond, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
tripartite motif-containing 65,COG_ONTOLOGY[90000064$Energy production and conversion]
tripartite motif-containing 65,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001628$IPR001841:Zinc finger, RING-type, 450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003406$IPR003879:Butyrophylin-like, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
tripartite motif-containing 65,SMART[760000158$SM00184:RING, 760000304$SM00336:BBOX]
tripartite motif-containing 65,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
tripartite motif-containing 65,UP_SEQ_FEATURE[850066667$chain:Tripartite motif-containing protein 65, 850103078$domain:B30.2/SPRY, 850106258$modified residue, 850117295$sequence variant, 850118638$zinc finger region:B box-type, 850118911$zinc finger region:RING-type]
tubulin tyrosine ligase-like family, member 11,INTERPRO[450003853$IPR004344:Tubulin-tyrosine ligase]
tubulin tyrosine ligase-like family, member 11,SP_PIR_KEYWORDS[790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000859$ligase]
tubulin tyrosine ligase-like family, member 11,UP_SEQ_FEATURE[850067135$chain:Tubulin polyglutamylase TTLL11, 850105582$domain:TTL]
tubulin, beta; similar to tubulin, beta 5; tubulin, beta pseudogene 2; tubulin, beta pseudogene 1,INTERPRO[450000187$IPR000217:Tubulin, 450002176$IPR002453:Beta tubulin, 450002643$IPR003008:Tubulin/FtsZ, GTPase domain, 450009944$IPR010916:TonB box, conserved site, 450012439$IPR013838:Beta tubulin, autoregulation binding site, 450016283$IPR017975:Tubulin, conserved site, 450016600$IPR018316:Tubulin/FtsZ, 2-layer sandwich domain]
tubulin, beta; similar to tubulin, beta 5; tubulin, beta pseudogene 2; tubulin, beta pseudogene 1,KEGG_PATHWAY[470038858$hsa04540:Gap junction, 470038898$hsa05130:Pathogenic Escherichia coli infection]
tubulin, beta; similar to tubulin, beta 5; tubulin, beta pseudogene 2; tubulin, beta pseudogene 1,PIR_SUPERFAMILY[630002432$PIRSF002306:tubulin]
tubulin, beta; similar to tubulin, beta 5; tubulin, beta pseudogene 2; tubulin, beta pseudogene 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000639$gtp-binding, 790000811$isopeptide bond, 790000953$methylation, 790000960$microtubule, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001592$ubl conjugation]
tubulin, beta; similar to tubulin, beta 5; tubulin, beta pseudogene 2; tubulin, beta pseudogene 1,UP_SEQ_FEATURE[850067103$chain:Tubulin beta chain, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict]
ubiquitin domain containing 2,INTERPRO[450000534$IPR000626:Ubiquitin, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup]
ubiquitin domain containing 2,SMART[760000186$SM00213:UBQ]
ubiquitin domain containing 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism]
ubiquitin domain containing 2,UP_SEQ_FEATURE[850068030$chain:Ubiquitin domain-containing protein 2, 850105602$domain:Ubiquitin-like, 850105852$helix, 850117295$sequence variant, 850118575$strand, 850118624$turn]
zinc finger protein 500,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 500,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450002887$IPR003309:Transcriptional regulator SCAN, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 500,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2, 760000377$SM00431:SCAN]
zinc finger protein 500,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 500,UP_SEQ_FEATURE[850101693$chain:Zinc finger protein 500, 850104552$domain:KRAB, 850105271$domain:SCAN box, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5]
